Unknown

Dataset Information

0

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment.


ABSTRACT: Control of Mycobacterium tuberculosis infection continues to be an issue, particularly in countries with a high tuberculosis (TB) burden in the tropical and sub-tropical regions. The effort to reduce the catastrophic cost of TB with the WHO's End TB Strategy in 2035 is still obstructed by the emergence of drug-resistant TB (DR-TB) cases as result of various mutations of the MTB strain. In the approach to combat DR-TB, several potential antitubercular agents were discovered as inhibitors for various existing and novel targets. Host-directed therapy and immunotherapy also gained attention as the drug-susceptibility level of the pathogen can be reduced due to the pathogen's evolutionary dynamics. This review is focused on the current progress and challenges in DR-TB treatment. We briefly summarized antitubercular compounds that are under development and trials for both DR-TB drug candidates and host-directed therapy. We also highlighted several problems in DR-TB diagnosis, the treatment regimen, and drug discovery that have an impact on treatment adherence and treatment failure.

SUBMITTER: Stephanie F 

PROVIDER: S-EPMC8143172 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4876017 | biostudies-literature
| S-EPMC7296033 | biostudies-literature
| S-EPMC7000172 | biostudies-literature
| S-EPMC4547509 | biostudies-other
| S-EPMC10732062 | biostudies-literature
| S-EPMC9004605 | biostudies-literature
| S-EPMC6124546 | biostudies-literature
| S-EPMC8695375 | biostudies-literature
| S-EPMC2673722 | biostudies-literature
| S-EPMC6955640 | biostudies-literature